Thu. 2 May 2024, 7:44am ET
Benzinga
Biotech, News, General
Statistically significant (p=0.0177) reduction in knee pain at six months
- Statistically significant (p<0.0001) maintenance of function at six months
- Transformational opportunity for Organogenesis to enter large and growing pain management market with innovative therapy
- Will address critical unmet medical need for all knee OA patients, including the most severe, if approved